Author Question: Critics of CAM argue that few double-blind, placebo-controlled trials have demonstrated ... (Read 95 times)

Garrulous

  • Hero Member
  • *****
  • Posts: 686
Critics of CAM argue that few double-blind, placebo-controlled trials have demonstrated effectiveness. CAM advocates argue that
 
  A) many techniques used in conventional medicine have not been evaluated by this method either.
  B) double-blind, placebo-controlled trials constitute a flawed method for evaluating health research.
  C) researchers are already biased against CAM; therefore, the research is not fair.
  D) the National Center for Complementary and Alternative Medicine is underfunded.

Question 2

A treatment is classified as alternative because
 
  A) the treatment has not been approved by the FDA.
  B) its practitioners are not licensed.
  C) research evidence has not confirmed its effectiveness.
  D) all of these are criteria for classification as alternative.



owenfalvey

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

A

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

For a complete list of videos, visit our video library